Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Sandborn

Showing results (61-70 of 186) with videos related to

Pageof 19
Sort By:
Gastroenterology|August 7, 2001
The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based studyW A Faubion, E V Loftus, W S Harmsen, et al.
Inflammatory Bowel Diseases|January 10, 2001
Clinical outcome and pharmacokinetics after addition of low-dose cyclosporine to methotrexate: a case study of five patients with treatment-resistant inflammatory bowel diseaseL J Egan, W J Tremaine, D C Mays, et al.
Alimentary Pharmacology & Therapeutics|August 13, 1998
Dialysis of the rectum for sampling drug concentrations in the luminal extracellular fluid of the gut: technique and precisionL J Egan, W J Sandborn, D C Mays, et al.
Alimentary Pharmacology & Therapeutics|February 17, 2006
CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, for steroid-dependent Crohn's disease: a randomized, double-blind, placebo-controlled trialB G Feagan, W J Sandborn, G Lichtenstein, et al.
Journal of Clinical Gastroenterology|July 1, 1993
High-volume postobstructive choleresis after transhepatic external biliary drainage resolves with conversion to internal drainageW J Sandborn, J B Gross, D E Larson, et al.
Inflammatory Bowel Diseases|August 24, 1999
Plasma and rectal adenosine in inflammatory bowel disease: effect of methotrexateL J Egan, W J Sandborn, D C Mays, et al.
Alimentary Pharmacology & Therapeutics|August 19, 2011
Early symptomatic response and mucosal healing with mesalazine rectal suspension therapy in active distal ulcerative colitis--additional results from two controlled studiesW J Sandborn, S Hanauer, G R Lichtenstein, et al.
Diseases of the Colon and Rectum|April 22, 1999
Misdiagnosis of specific cytomegalovirus infection of the ileoanal pouch as refractory idiopathic chronic pouchitis: report of two casesM Muñoz-Juarez, J H Pemberton, W J Sandborn, et al.
Journal of Clinical Pharmacology|January 1, 1991
The pharmacokinetics and colonic tissue concentrations of cyclosporine after i.v., oral, and enema administrationW J Sandborn, R M Strong, S C Forland, et al.
Alimentary Pharmacology & Therapeutics|June 27, 2007
MMX Multi Matrix System mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trialsW J Sandborn, M A Kamm, G R Lichtenstein, et al.
Pageof 19

Showing results (61-70 of 186) with videos related to

Sort By:
Pageof 19
Gastroenterology|August 7, 2001
The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based studyW A Faubion, E V Loftus, W S Harmsen, et al.
Inflammatory Bowel Diseases|January 10, 2001
Clinical outcome and pharmacokinetics after addition of low-dose cyclosporine to methotrexate: a case study of five patients with treatment-resistant inflammatory bowel diseaseL J Egan, W J Tremaine, D C Mays, et al.
Alimentary Pharmacology & Therapeutics|August 13, 1998
Dialysis of the rectum for sampling drug concentrations in the luminal extracellular fluid of the gut: technique and precisionL J Egan, W J Sandborn, D C Mays, et al.
Alimentary Pharmacology & Therapeutics|February 17, 2006
CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, for steroid-dependent Crohn's disease: a randomized, double-blind, placebo-controlled trialB G Feagan, W J Sandborn, G Lichtenstein, et al.
Journal of Clinical Gastroenterology|July 1, 1993
High-volume postobstructive choleresis after transhepatic external biliary drainage resolves with conversion to internal drainageW J Sandborn, J B Gross, D E Larson, et al.
Inflammatory Bowel Diseases|August 24, 1999
Plasma and rectal adenosine in inflammatory bowel disease: effect of methotrexateL J Egan, W J Sandborn, D C Mays, et al.
Alimentary Pharmacology & Therapeutics|August 19, 2011
Early symptomatic response and mucosal healing with mesalazine rectal suspension therapy in active distal ulcerative colitis--additional results from two controlled studiesW J Sandborn, S Hanauer, G R Lichtenstein, et al.
Diseases of the Colon and Rectum|April 22, 1999
Misdiagnosis of specific cytomegalovirus infection of the ileoanal pouch as refractory idiopathic chronic pouchitis: report of two casesM Muñoz-Juarez, J H Pemberton, W J Sandborn, et al.
Journal of Clinical Pharmacology|January 1, 1991
The pharmacokinetics and colonic tissue concentrations of cyclosporine after i.v., oral, and enema administrationW J Sandborn, R M Strong, S C Forland, et al.
Alimentary Pharmacology & Therapeutics|June 27, 2007
MMX Multi Matrix System mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trialsW J Sandborn, M A Kamm, G R Lichtenstein, et al.
Pageof 19